The potential risk of neoadjuvant chemotherapy in breast cancer patients–results from a prospective randomized trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-07).

Taucher S, Steger GG, Jakesz R, Tausch C, Wette V, Schippinger W, Kwasny W, Reiner G, Greil R, Dubsky P, Poestlberger S, Tschmelitsch J, Samonigg H, Gnant M Breast Cancer Res Treat. 2008 Nov,112(2):309-16. Epub 2007 Dec 14.

Anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients receiving adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy.

Dubsky P, Sevelda P, Jakesz R, Hausmaninger H, Samonigg H, Seifert M, Denison U, Mlineritsch B, Steger G, Kwasny W, Stöger H, Bartsch R, Stierer M, Taucher S, Fridrik M, Schippinger W, Greil R, Pötter R, Gnant M Clin Cancer Res. 2008 Apr 1,14(7):2082-7. doi: 10.1158/1078-0432.CCR-07-2068.

Diagnostic algorithms, monitoring, prognostication, and therapy in chronic myeloid leukemia (CML): a proposal of the Austrian CML platform

Valent, P, Lion, T, Wolf, D, Sillaber, C, Agis, H, Petzer, A, Lang, A, Kalhs, P, Geissler, D, Greil, R, Linkesch, W, Burgstaller, S, Thaler, J, Gastl, G WIEN KLIN WOCHENSCHR. 2008, 120(21-22): 697-709.

Chemotherapy in gastric cancer.

Wöll E, Devries A, Eisterer W, Hejna M, Keil F, Stein H, Zacherl J, Greil R. Anticancer Res. 2008 Mar-Apr,28(2B):1213-9.

Tumour-immune cell interactions modulated by chemokines.

Jöhrer K, Pleyer L, Olivier A, Maizner E, Zelle-Rieser C, Greil R. Expert Opin Biol Ther. 2008 Mar,8(3):269-90. doi: 10.1517/14712598.8.3.269 .

Cyclin D1 expression in breast cancer patients receiving adjuvant tamoxifen-based therapy.

Rudas M, Lehnert M, Huynh A, Jakesz R, Singer C, Lax S, Schippinger W, Dietze O, Greil R, Stiglbauer W, Kwasny W, Grill R, Stierer M, Gnant MF, Filipits M Clin Cancer Res. 2008 Mar 15,14(6):1767-74. doi: 10.1158/1078-0432.CCR-07-4122.

Renal safety profiles of ibandronate 6 mg infused over 15 and 60 min: a randomized, open-label study.

von Moos R, Caspar CB, ThГјrlimann B, Angst R, Inauen R, Greil R, Bergstrom B, Schmieding K, Pecherstorfer M. Ann Oncol. 2008 Jul,19(7):1266-70. doi: 10.1093/annonc/mdn038. Epub 2008 Mar 11.

A phase I/II study of bortezomib and capecitabine in patients with metastatic breast cancer previously treated with taxanes and/or anthracyclines.

Schmid P, KГјhnhardt D, Kiewe P, Lehenbauer-Dehm S, Schippinger W, Greil R, Lange W, Preiss J, Niederle N, Brossart P, Freier W, KГјmmel S, Van de Velde H, Regierer A, Possinger K. Ann Oncol. 2008 May,19(5):871-6. doi: 10.1093/annonc/mdm569. Epub 2008 Jan 21.

Arsenic trioxide induces apoptosis preferentially in B-CLL cells of patients with unfavourable prognostic factors including del17p13.

Merkel O, Heyder C, Asslaber D, Hamacher F, Tinhofer I, Holler C, Stöcher M, Prokesch A, Papak C, Scheideler M, Trajanoski Z, Greil R. J Mol Med (Berl). 2008 May,86(5):541-52. doi: 10.1007/s00109-008-0314-6. Epub 2008 Feb 23.

MDM2 SNP309 is associated with poor outcome in B-cell chronic lymphocytic leukemia.

Gryshchenko I, Hofbauer S, Stoecher M, Daniel PT, Steurer M, Gaiger A, Eigenberger K, Greil R, Tinhofer I. J Clin Oncol. 2008 May 10,26(14):2252-7. doi: 10.1200/JCO.2007.11.5212.